Product code POK— Radiology
Brainomix 360 e-ASPECTS
- Classification name
- Computer-Assisted Diagnostic Software For Lesions Suspicious For Cancer
- Device class
- Class 2
- Regulation
- 21 CFR 892.2060
- Advisory panel
- Radiology
- Total cleared
- 23
- First cleared
- Most recent
FDA classification definition
“Assist users in characterizing lesions identified on acquired medical images”
Market context for product code POK
FDA has cleared devices under product code POK between 2017 and 2026, filed by 15 applicant companies. No FDA device recalls reference this product code. Class II devices are moderate-risk and subject to general and special controls; most reach market through 510(k) clearance by demonstrating substantial equivalence to a predicate device.
Clearances per year
- 2026
- 2025
- 2024
- 2023
- 2022
- 2021
- 2020
- 2019
- 2017
Top applicants under product code POK
Recent clearances under product code POK
- K253884 — Koios DS (3.8)
- K261519 — Sonio Suspect
- K254161 — Automated Aortic Stenosis Software (AutoAS)
- K251769 — RevealAI-Lung
- K252294 — Fetal EchoScan (v1.2)
- K250221 — StrokeSENS ASPECTS Software Application
- K251071 — Fetal EchoScan (v1.1)
- K243614 — Sonio Suspect
- K243294 — Brainomix 360 e-ASPECTS
- K242130 — Koios DS
- K242342 — Fetal EchoScan
- K241245 — EchoSolv AS
- K234141 — AISAP Cardio V1.0
- K233342 — CINA-ASPECTS
- K232156 — Rapid ASPECTS (v3)
- K221564 — Brainomix 360 e-ASPECTS
- K221624 — Avenda Health AI Prostate Cancer Planning Software
- K212616 — Koios DS
- K202300 — Optellum Virtual Nodule Clinic, Optellum software, Optellum platform
- K201555 — EchoGo Pro
- K200760 — Rapid ASPECTS
- K190442 — Koios DS for Breast
- DEN170022 — QuantX
Data sourced from openFDA. This site is unofficial and independent of the FDA.